Qianjin Pharmaceutical (600479.SH): Products such as didroprogesterone tablets will be selected for centralized procurement of drugs nationwide

Zhitong Finance App News, Qianjin Pharmaceutical (600479.SH) announced that on July 31, 2026, the company and its subsidiary Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. participated in the bidding process for the 12th batch of centralized national drug procurement organized by the State Organization Drug Joint Procurement Office. The company and Qianjin Xiangjiang Pharmaceutical plan to select 4 products, including didroprogesterone tablets, for this centralized procurement.

This centralized drug procurement is the 12th batch of centralized procurement of national drugs organized by the state. In terms of implementation, medical institutions are required to prioritize the use of selected varieties from centralized procurement and ensure that the agreed procurement volume is completed. If the company subsequently signs a procurement contract and implements it, it will help the above products to quickly open up the domestic sales market, increase market share, enhance the company's brand influence, and have a positive impact on the company's future operations.